Pulmonary fibrosis inhibited by pentraxin-2/SAP in research study
Thursday, February 10, 2011 - 14:01
in Health & Medicine
MALVERN, PA -- February 10, 2011 -- Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication...